The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2010
DOI: 10.1098/rspb.2010.1747
|View full text |Cite
|
Sign up to set email alerts
|

Subretinal electronic chips allow blind patients to read letters and combine them to words

Abstract: A light-sensitive, externally powered microchip was surgically implanted subretinally near the macular region of volunteers blind from hereditary retinal dystrophy. The implant contains an array of 1500 active microphotodiodes (‘chip’), each with its own amplifier and local stimulation electrode. At the implant's tip, another array of 16 wire-connected electrodes allows light-independent direct stimulation and testing of the neuron–electrode interface. Visual scenes are projected naturally through the eye's le… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

12
772
0
35

Year Published

2011
2011
2018
2018

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 775 publications
(842 citation statements)
references
References 35 publications
12
772
0
35
Order By: Relevance
“…Patients who are legally blind are the key target population of these therapies. Three different strategies are being investigated: (1) the implantation of differentiated or undifferentiated photoreceptors, 19 (2) electronic retinal implants, [20][21][22] and (3) the subject of this review, so-called 'optogenetic' approaches, [23][24][25] which use genetically encoded light sensors to make cells light responsive. [26][27][28] The success of cellimplantation approaches depends on the formation of functional synapses between the implanted photoreceptors and endogenous bipolar cells, and on functional retinal pigment epithelium to supply photoreceptors with 11-cis-retinal.…”
Section: Potential Therapies For Retinitis Pigmentosamentioning
confidence: 99%
See 1 more Smart Citation
“…Patients who are legally blind are the key target population of these therapies. Three different strategies are being investigated: (1) the implantation of differentiated or undifferentiated photoreceptors, 19 (2) electronic retinal implants, [20][21][22] and (3) the subject of this review, so-called 'optogenetic' approaches, [23][24][25] which use genetically encoded light sensors to make cells light responsive. [26][27][28] The success of cellimplantation approaches depends on the formation of functional synapses between the implanted photoreceptors and endogenous bipolar cells, and on functional retinal pigment epithelium to supply photoreceptors with 11-cis-retinal.…”
Section: Potential Therapies For Retinitis Pigmentosamentioning
confidence: 99%
“…Some blind patients can read letters and even words. 22 In optogenetic approaches, a genetically encoded light sensor sits in the membrane of a retinal cell. The generated current flows across the cell membrane and thus activates or inactivates that particular cell.…”
Section: Potential Therapies For Retinitis Pigmentosamentioning
confidence: 99%
“…1C) which replaces the vitreous body in retinal implant patients after vitrectomy [4]. The distant return electrode used in the retinal implant [5] was simulated by setting the outer boundary conditions of the retinal layer to ground potential (Fig. 1D) [6].…”
Section: Methodsmentioning
confidence: 99%
“…In contrast to traditional gene therapy approaches whose goal is to correct a mutated gene and restore normal protein function, optogenetics introduces novel light sensitive proteins into neurons like bipolar cells and ganglion cells to cause them to function as photoreceptors to restore some visual function (Garg and Federman 2013;Packer et al 2013;Yonehara et al 2013). Retinal prostheses typically consist of arrays of photodiodes that are surgically implanted beneath or above the retina to electrically stimulate the remaining inner retinal cells (Loudin et al 2007;Zrenner et al 2011). Another strategy that is being pursued for patients with very advanced disease is a three-dimensional transplants consisting of stem-cell-derived sheets of photoreceptors and RPE cells grown on a biocompatible polymer scaffold (Zhang et al 2007;Yao et al 2011;Tucker et al 2011a;Shepherd et al 2013).…”
Section: Stem Cells and Genetics Of Retinal Degenerationsmentioning
confidence: 99%